UPDATE : Friday, June 5, 2020
Medytox’s faking data unpunishable due to expired statute of limitations by Jeong Sae-im 2020-04-22 11:28
Abclon derives clinical materials for CAR-T treatment of ovarian cancer by Shim Hyun-tai 2020-04-21 17:49
Multidisciplinary cure is mainstream cancer treatment but cumbersome by Park Gi-taek 2020-04-21 17:09
Whistleblowers, shareholders furious over Medytox’s rebuttal by Jeong Sae-im 2020-04-21 15:19
ImmuneMed confident of drug candidate’s effect on Covid-19 by Jeong Sae-im 2020-04-21 13:23
Medytox files suit to cancel administrative order by Shim Hyun-tai 2020-04-20 16:37
DM Bio signs CDMO contract with Abion for antibody treatment by Shim Hyun-tai 2020-04-17 16:03
Medytox CEO charged with making, selling botulinum toxin illegally by Jeong Sae-im 2020-04-17 16:00
Researchers to test asthma drug to treat Covid-19 by Kim Yun-mi 2020-04-16 16:20
Bukwang to test its antiviral drug against Covid-19 by Jeong Sae-im 2020-04-16 12:20
Opdivo’s indication expanded to esophageal squamous cell carcinoma by Kim Yun-mi 2020-04-16 10:48
Pasteur, Daewoong to co-develop COVID-19 drug from parasiticide by Shim Hyun-tai 2020-04-14 17:49
Gilead revised clinical design of potential COVID-19 drug remdesivir. Why? by Kim Yun-mi 2020-04-10 15:36
Executive salaries highest at Samsung Biologics, Celltrion by Jeong Sae-im 2020-04-09 11:13
Review of cancer drug benefits delayed amid social distancing by Kim Yun-mi 2020-04-08 13:46
Jeil’s oral cancer treatment wins extended indication for NSCLC by Shim Hyun-tai 2020-04-06 15:33
Pfizer, MSD put off reorganizing due to COVID-19 by Kim Yun-mi 2020-04-03 17:09
GC Pharma to supply plasma treatment for COVID-19 this year by Shim Hyun-tai 2020-04-02 18:11
Genexine to release results of using Hyleukin-7 & Keytruda at ASCO by Shim Hyun-tai 2020-04-02 17:01
AptaBio wins patent for blood cancer therapy by Shim Hyun-tai 2020-04-02 16:17
Back to Top